Cetirizine and Loratadine: A Comparison Using the ED50 in Skin Reactions

Author:

Ramboer I1,Bumbacea R2,Lazarescu D2,Radu JR2

Affiliation:

1. UCB SA Pharma Sector, Braine l'Alleud, Belgium

2. Malaxa Hospital, Bucharest, Romania

Abstract

To quantify objectively the comparative potencies of the antihistamines, loratadine and cetirizine, we determined the dose that inhibits histamine-induced skin reactions by 50% of the maximum response (ED50) for each drug. Cetirizine at 2.5, 5 or 10 mg, loratadine at 10, 20 or 40 mg or placebo were given to 14 healthy female subjects in a randomized double-blind crossover design. Inhibition of the wheal and flare response to the histamine prick test (10, 100 and 500 mg/ml) was evaluated. Depending on the histamine concentrations, the ED50 for wheals were in the ranges 4.3–4.7, 2.1–2.2 and 1.7–1.9 mg cetirizine, 2, 4 and 6 h after dosing, respectively. For loratadine, the ED50 for wheals were in the ranges 35.6 – > 40, 9.1–24.1 and 9.1–13.9 mg, 2, 4 and 6 h after dosing, respectively. Calculation of the ED50 demonstrated that, on average, cetirizine is seven to nine times more potent than loratadine at inhibiting wheal and flare reactions.

Publisher

SAGE Publications

Subject

Biochemistry, medical,Cell Biology,Biochemistry,General Medicine

Cited by 9 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

1. Cetirizine;xPharm: The Comprehensive Pharmacology Reference;2008

2. Increasing the dose of cetirizine may lead to better control of chronic idiopathic urticaria: an open study of 21 patients;British Journal of Dermatology;2007-10

3. Basis of antihistamines use in atopic dermatitis;Russian Journal of Allergy;2007-09-15

4. Experimental models for the evaluation of treatment of allergic rhinitis;Annals of Allergy, Asthma & Immunology;2006-02

5. Second-Generation Antihistamines;Drugs;2005

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3